COVID-19 vaccine (in partnership with BioNTech)

URI: https://gptkb.org/entity/COVID-19_vaccine_(in_partnership_with_BioNTech)
GPTKB entity
Statements (46)
Predicate Object
gptkbp:instanceOf vaccine
gptkbp:administeredBy intramuscular injection
gptkbp:age 12 years and older
gptkbp:alsoKnownAs gptkb:BNT162b2
gptkb:Comirnaty
gptkbp:approvedBy gptkb:WHO
gptkb:FDA
gptkb:EMA
2020
gptkbp:boosterRecommended yes
gptkbp:boosters yes
gptkbp:category gptkb:COVID-19_vaccines
mRNA vaccines
BioNTech products
Pfizer products
vaccines approved by the EMA
vaccines approved by the FDA
gptkbp:clinicalTrialPhase 2020
gptkbp:contains nucleoside-modified mRNA
gptkbp:developedBy gptkb:Pfizer
gptkb:BioNTech
gptkbp:distribution global
gptkbp:effect over 90% in clinical trials
gptkbp:emergencyServices granted
gptkbp:EUBrandName gptkb:Comirnaty
gptkbp:excludes adjuvant
live virus
preservative
gptkbp:form two doses
https://www.w3.org/2000/01/rdf-schema#label COVID-19 vaccine (in partnership with BioNTech)
gptkbp:marketedAs gptkb:Pfizer
gptkb:BioNTech
gptkbp:patent gptkb:Pfizer
gptkb:BioNTech
gptkbp:regulatorySubmission multiple countries
gptkbp:sideEffect mild to moderate
rare severe allergic reactions
gptkbp:storage -70°C
gptkbp:target gptkb:COVID-19
gptkbp:technology lipid nanoparticle delivery
gptkbp:USBrandName gptkb:Comirnaty
gptkbp:vaccineType vaccine
gptkbp:variantAdaptedVersions yes
gptkbp:WHOEmergencyUseListing December 2020
gptkbp:bfsParent gptkb:Shanghai_Fosun_Pharmaceutical_Development_Co.,_Ltd.
gptkbp:bfsLayer 7